Oligovax is the exclusive licensee of patents filed by the Assistance Publique – Hôpitaux de Paris (AP-HP), with the right to grant sub-licenses.
Several patents have been granted to Oligovax:
Utilisation d'oligonucléotides stabilisés comme principe actif antitumoral. Propriétaires AP/HP et INSERM. Inventor : AF Carpentier.19/3/99. Brevet Fr 99 03433, EP 1162982 B1
Use of stabilised oligonucleotides for preparing a medicine with antitumor activity. Propriétaires AP/HP et INSERM. Inventor : AF Carpentier. 19/3/99. US n°7,700,569.
Use Of Stabilised Oligonucleotides For Preparing A Medicament With Antitumor Activity. Propriétaires AP/HP et INSERM. Inventeur : AF Carpentier. 28/9/2001. Brevet US No. 7,108,844.
